ARCHIVES

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

This article is from The Cancer Letter archive.

Vol. 32 No. 29 | July 28, 2006

Download PDF Visit The Full Archive

Related Articles

ASCO Calls For New Clinical Study Section, Endorses NCAB Action In Senate Testimony

July 23, 1993

NIH Biennial Report Offers Research Portrait

September 24, 2010

In Brief: McDonough Leaves Komen Foundation; Henderson To Head Salk Institute; Alabama Recruits Two

December 4, 1992

Solomon Garb’s Questions/Answers

January 9, 1981

NSABP Breast Cancer Prevention Trial Reports Final Results On Tamoxifen

November 25, 2005

Also David Schwartz of Duke University to head NIEHS.

October 29, 2004